Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Jack Wyant
AddedMar 31, 2024
UpdatedMay 1, 2026
Jack Wyant

Jack Wyant

Founder, Blue Chip Venture Company

Jack Wyant's Career

Blue Chip Venture Company
Blue Chip Venture Company

Cincinnati, OH, US

Founder
Union Springs Pharmaceuticals
Union Springs Pharmaceuticals

Union Star, KY, US

Board Member· Board
Core2 Group
Core2 Group

McLean, VA, US

Board Member· Board
ShareThis
ShareThis

Palo Alto, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Jack Wyant's Career

Blue Chip Venture Company
Blue Chip Venture Company
Investment FirmInvestment Firm111990Cincinnati, OH, US
Founder

Leadership at Blue Chip Venture Company

Frank E WoodFrank E WoodBoard Member

Similar to Blue Chip Venture Company

Sierra Wasatch CapitalSierra Wasatch CapitalTruckee, CA, USest. 2016Sierra Wasatch CapitalTruckee, CA, US · est. 2016

Venture capital fund investing in innovative digital media and future-focused tech solutions.

Investment Firm2
Math Venture PartnersMath Venture PartnersChicago, IL, USest. 2014Math Venture PartnersChicago, IL, US · est. 2014

Math Venture Partners: A seasoned fund managing early to growth-stage tech and digital firms.

Investment Firm7
Red & Blue VenturesRed & Blue VenturesPhiladelphia, PA, USest. 2016Red & Blue VenturesPhiladelphia, PA, US · est. 2016

Red & Blue Ventures LLC: A venture capital firm investing in early-stage IT and software companies in key US cities.

Investment Firm5
Techgrowth OhioTechgrowth OhioAthens, OH, USest. 2008Techgrowth OhioAthens, OH, US · est. 2008

TechGROWTH Ohio: A venture capital firm investing in pre-seed to startup stage companies across diverse sectors in Ohio.

Investment Firm7
Union Springs Pharmaceuticals
Union Springs Pharmaceuticals
Series A$5M2002008Union Star, KY, US
Board Member· Board

Similar to Union Springs Pharmaceuticals

Solaris PharmaSolaris PharmaBridgewater Township, NJ, USGenerics, Pharmaceuticalsest. 2014Solaris PharmaBridgewater Township, NJ, US · est. 2014

Pharmaceutical R&D firm, Solaris Pharma, specializes in generic and specialty products.

Series A · $23.4M31
Concours PharmaceuticalsConcours PharmaceuticalsTrenton, NJ, USPharmaceuticalsest. 2018Concours PharmaceuticalsTrenton, NJ, US · est. 2018

Concours Pharmaceuticals: Innovating oral drug delivery for advanced pharmaceutical development.

Seed · $2.7M30
SpringWorks TherapeuticsSpringWorks TherapeuticsStamford, CT, USPharmaceuticalsest. 2017SpringWorks TherapeuticsStamford, CT, US · est. 2017

SpringWorks Therapeutics develops pharmaceutical drugs for oncology, neurology, and rare genetic diseases in the US.

Public · $1B227
US Specialty FormulationsUS Specialty FormulationsBethlehem, PA, USPharmaceuticalsest. 2013US Specialty FormulationsBethlehem, PA, US · est. 2013

US Specialty Formulations produces FDA-approved sterile injectable pharmaceuticals for healthcare providers globally.

Angel · $75k14
Core2 Group
Core2 Group
Series A$10.4M302013McLean, VA, US
Board Member· Board

Leadership at Core2 Group

Tom DaileyTom DaileyBoard Member
Joe DudaJoe DudaBoard Member
Michael Dendy YoungMichael Dendy YoungBoard Member
Mark K WrightMark K WrightBoard Member

Similar to Core2 Group

CorelyticsCorelyticsBellevue, WA, USFinancial Dashboardest. 2005CorelyticsBellevue, WA, US · est. 2005

Coreconnex Inc provides a management dashboard for businesses to monitor trends and forecast scenarios.

Angel · $100k30
PrevederePrevedereColumbus, OH, USAnalytics Softwareest. 2012PrevedereColumbus, OH, US · est. 2012

Prevedere offers a cloud-based platform for predictive analytics and industry insights, aiding leaders in strategic decision-making.

Series D · $67.3M74
EarlyBirdEarlyBirdChicago, IL, USAnalytics, Softwareest. 2019EarlyBirdChicago, IL, US · est. 2019

Earlybird: An analytics provider, building smart data-driven software for businesses.

Seed · $10.9M30
CShine AICShine AINew York City, NY, USData Analyticsest. 2021CShine AINew York City, NY, US · est. 2021

Intelligent, data-driven platform for creative businesses.

Pre-Seed · $50k2
ShareThis
ShareThis
Public$82.3M1162007Palo Alto, CA, US
Board Member· Board

Leadership at ShareThis

Alex OsadzinskiAlex OsadzinskiBoard Member
Blair GarrouBlair GarrouBoard Member
Dana HayesDana HayesCEO
Marc WeiserMarc WeiserBoard Member
Kurt AbrahamsonKurt AbrahamsonBoard Member
Tim SchigelTim SchigelFounder

Jack Wyant's Similar Executives & Operators

Achmad ZakyAchmad ZakyCo-Founder · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakChi-hyung SongChi-hyung SongBoard Member · DunamuHaeil YiHaeil YiCo-Founder · DunamuHyoung-nyon KimHyoung-nyon KimCo-Founder · Dunamu

People Similar to Jack Wyant

Thomas J. Davis, Jr.Thomas J. Davis, Jr.Founder · Mayfield FundDavid CreminDavid CreminCo-Founder · DFJ FrontierDave BerkusDave BerkusBoard Member · Tech Coast AngelsMichael AbbottMichael AbbottBoard Member · USC Viterbi School of EngineeringDavid FialkowDavid FialkowBoard Member · DatalogixDon ValentineDon ValentineFounder · Sequoia Capital